MODERN DIAGNOSTICS OF JOINT DAMAGE IN PATIENTS WITH REACTIVE ARTHRITIS
Keywords:
reactive arthritis, joint syndrome, destruction, structural alterations, Chlamydia trachomatis, cartilage, pro-inflammatory cytokines, synovial liquid, enthesopathy, synovitisAbstract
In the world, the problem of diagnosing reactive arthritis has not yet been solved, and several studies are being carried out to study the practical significance of an accurate diagnosis of this disease in the early stages. We defined the mechanism of cartilage early destruction in the development of apparent structural alterations in joints in reactive arthritis and its role in the deterioration of articulate syndrome.
References
Starodubtseva I.A., Vasilyeva L.V. Comparative analysis of cartilage oligomere matrix protein in blood serum of the patients with skeletal system diseases // Clinical laboratory diagnosis. 2016. Vol. 61. № 2. p. 83-86. (in Russian)
Carrasco R., Barton A. Biomarkers of outcome in rheumatoid arthritis // Rheumatology Reports.-2010.-Vol. 2 (1). P. 26-38.
Mease P.J. The potential roles for novel biomarkers in rheumatoid arthritis assessment // Clin. Exp. Rheumatol. - 2011. - Vol. 29. - P. 567-574.
Kunder Y.V. Reactive arthritis // Medical news. 2015. №11. p. 8–13. (in Russian)
Khripunova I.G., Jurbina N.V. Reactive arthritis // Guidelines. Stavropol, 2013, pp 3-5. (in Russian)
Alekseyeva Y.I., Jolobova Y.S. Reactive arthritis in children. Problems of modern pediatrics, 2013, Vol.2, №1, p. 51-56. (in Russian)
Gniloribov A.M. The role of cartilage oligomere matrix protein in the diagnosis of joint damages // Ukr. Rheum. Jour. 2008. 17 (3). p. 8-11. (in Russian)
Lotz M., Martel-Pelletier J., Christiansen C., Brandi M.L., Bruyere O., Chapurlat R. et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann. Rheum. Dis. 2013; 72 (11): 1756-1763.
Starodubtseva I.A., Vasilyeva L.V. Secondary osteoarthrosis in rheumatic arthritis // Clinitcist, 2015, №1, p 24-29. (in Russian)
Marti C., Neidhart M. Cartilage Oligomerix Matrix Protein (COMP): Die Rolle eines nichtkollagenen Knorpel-Matrix-Proteins als Marker der Kran-kenheitsaktivitat und Gelenkzerstorung bei Patienten mit rheumatoi-der Arthritis und Arthrose. Z Rheum. 2016; 58: 79-87.
Tseng S., Reddi A.H., Di Cesare P.E. Cartilage oligomeric matrix protein (COMP): a biomarker of arthritis. Biomark. Insights. 2015; 17 (4): 33-44.
Novikov a.A., Aleksandrova Y.N. Role of cytokines in the pathogenesis of rheumatoid arthritis // scientific-practical rheumatology. 2012. №2, p. 71–82. (in Russian)
